Disruptions in BMP/TGF-β signalling have been reported in a variety of neurological diseases, notably in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS) [217]. The gene discussed is TGFB1; the disease is amyotrophic lateral sclerosis.